GET THE APP

Chinese Medicine Impact Factor | Open Access Journals

Journal of Pharmacognosy & Natural Products

ISSN: 2472-0992

Open Access

Submit Manuscript

Chinese Medicine Impact Factor

Chinese Medicine, the official diary of the International Society for Chinese Medicine, is an open access, peer-investigated online diary that envelops all parts of exploration on Chinese medication, gave the material, strategies, results, and ends are proof based, deductively supported, and ethical. Areas of premium incorporate home grown medication, wellbeing food, clinical sustenance, needle therapy, vitality research, clinical instruction, social trade, and specialized interpretation. Chinese Medicine is an open access diary distributing proof based, deductively advocated exploration and audit papers in all parts of Chinese medication, including - yet not restricted to - science, pharmacology, pharmaceutics, designing, clinical applications and economics that are pertinent and critical to Chinese medication. High impact factor of a journal is appraised by dividing the number of current year citations to the source items published in that journal during the previous two years.

High Impact List of Articles

Conference Proceedings

Intravenous opioids for acute postoperative pain control: Comparative study
Amany K. Aboelhussein
Posters & Accepted Abstracts: Journal of Formulation Science & Bioavailability
Intravenous opioids for acute postoperative pain control: Comparative study
Amany K. Aboelhussein
Posters & Accepted Abstracts: Journal of Formulation Science & Bioavailability
Antihypertensive and heart rate reduction effect of gambir leaves extract (Uncaria gambir (H.) Roxb) in NaCl induced-hypertensive rats
Tika Nurhasanah, Fadhlina Chany Saputri, Santi Purna Sari and Putri Syahida Agustina
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
Antihypertensive and heart rate reduction effect of gambir leaves extract (Uncaria gambir (H.) Roxb) in NaCl induced-hypertensive rats
Tika Nurhasanah, Fadhlina Chany Saputri, Santi Purna Sari and Putri Syahida Agustina
Scientific Tracks Abstracts: Pharmacoeconomics: Open Access
The use of real-time polymerase chain reaction (rT-PCR) technologies to screen for the presence of total bacteria in a liquid sample
Andy Moreno
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
The use of real-time polymerase chain reaction (rT-PCR) technologies to screen for the presence of total bacteria in a liquid sample
Andy Moreno
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
A double blind, phase 1, randomized, parallel-group, single dose, 2 arm, biosimilar study, of a ?New Biologic? and ?Comparator?, intravenously administered to healthy subjects
Krishna Menon
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
A double blind, phase 1, randomized, parallel-group, single dose, 2 arm, biosimilar study, of a ?New Biologic? and ?Comparator?, intravenously administered to healthy subjects
Krishna Menon
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilar regulations in India: Current scenario
Smita S. Singhania
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Biosimilar regulations in India: Current scenario
Smita S. Singhania
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 606

Journal of Pharmacognosy & Natural Products received 606 citations as per Google Scholar report

Journal of Pharmacognosy & Natural Products peer review process verified at publons

Indexed In

Related Links

Open Access Journals